Exposure to alirocumab during the first trimester of pregnancy: A case report

Volume: 113, Issue: 15, Pages: 1156 - 1160
Published: Jun 8, 2021
Abstract
Familial hypercholesterolemia can be efficiently treated with combined lipid-lowering drugs. Lipid-lowering drugs are usually withdrawn for pregnancy and breastfeeding, ideally preconception, followed by lipid apheresis, however, careful plans can be precipitated due to unexpected pregnancy.A 28-year old woman with familial hypercholesterolemia due to heterozygous LDLR mutations had an LDL-cholesterol level at 14.6 mmol/L and Lp(a) at 1150 mg/L....
Paper Details
Title
Exposure to alirocumab during the first trimester of pregnancy: A case report
Published Date
Jun 8, 2021
Volume
113
Issue
15
Pages
1156 - 1160
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.